• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2010-2019  
Title Created Date
XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells 29 April 2014
Therapeutic applications of melatonin 29 April 2014
New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin 14 April 2014
Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review 14 April 2014
Melatonin and cancer: current knowledge and its application to oral cavity tumours 07 April 2014
Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells 07 April 2014
All trans-retinoic acid (ATRA) induces re-differentiation of early transformed breast epithelial cells 01 April 2014
Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma 20 March 2014
The role of prolactin receptor in GH signaling in breast cancer cells 20 March 2014
Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism 19 March 2014
Display # 

Page 163 of 172

  • Start
  • Prev
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • Next
  • End

Search

Follow us...

Latest

  • Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers
  • Updated perspectives on vitamin D deficiency, screening, supplementation and clinical guidance
  • Melatonin: an inhibitor of breast cancer
  • All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma
  • Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice
  • Effect of oral melatonin on sleep quality, fatigue, and caregiver sleep perception in patients with head and neck cancer: A randomized double-blind placebo-controlled trial
  • Mechanisms Underlying Tumor Suppressive Properties of Melatonin
  • Vitamin D supplementation is associated with reduced risk of hepatobiliary malignancy in patients with primary sclerosing cholangitis
  • Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells
  • A case control study to determine the frequency of vitamin d deficiency in carcinoma breast in females of local population of Rawalpindi and Islamabad area
  • In vitro and in vivo antitumor activity of melatonin receptor agonists
  • Proteoformics-driven new concept of human growth hormone in clinical endocrinology
  • The role of melatonin in colorectal cancer treatment: a comprehensive review
  • The Role of Melatonin in Colorectal Cancer
  • Ameliorative effects of melatonin on radiotherapy-induced apoptotic and inflammatory responses in rat parotid gland
  • The role of melatonin in immuno-enhancement: potential application in cancer
  • Circulating neuroendocrine markers in patients with prostate carcinoma
  • Somatostatin and the treatment of cancer

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer